Medicare covers colon test
11:41AM Genomic Health announces medicare coverage for Oncotype DX colon cancer test (GHDX) 19.64 -0.23 : Co announced that Palmetto GBA, the designated national contractor for its Oncotype DX colon cancer test, has established a formal coverage policy for all Medicare patients. The Oncotype DX colon cancer test has been clinically validated to predict risk of recurrence in patients with stage II colon cancer.